Last update:

Weight management news

Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports

Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) ...

New study finds weight stigma may keep young adults from seeking medical care

New research from the University of Minnesota Medical School highlights how weight stigma in health care settings may prevent young adults from seeking medical care, particularly those experiencing severe disordered eating ...

Weekly weight-loss injection combo shows promise

Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health ...

RNA switch lets drugs control gene therapy protein production

Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable ...

China approves first oral GLP-1 weight-loss pill

China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.

Night owls who eat late may face higher health risks

A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health and metabolic disease, offering new insights into why some individuals with obesity may face a risk of inflammation ...

Why obesity affects males and females differently

University of California, Riverside, scientists have an explanation for why males and females respond differently to obesity. They report in PNAS Nexus that certain immune cell populations in fat tissue may protect against ...

Obesity drugs could lead to new ways to protect the brain

Drugs such as semaglutide and tirzepatide are already used to treat obesity and type 2 diabetes, but they also influence biological processes important for brain function. In a new review published in Science, researchers ...